NORTH AMERICAN VACCINE has a total of 12 patent applications. Its first patent ever was published in 1991. It filed its patents most often in Poland, Czechia and Czechoslovakia. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are ADJUVANTIX LTD, SL VAXIGEN INC and VAXIMM AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | Poland | 4 | |
#2 | Czechia | 3 | |
#3 | Czechoslovakia | 2 | |
#4 | Ireland | 2 | |
#5 | Hungary | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Climate change adaptation technologies | |
#4 | Therapeutic chemical compounds | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Michon Francis | 8 |
#2 | Blake Milan S | 3 |
#3 | Liang Shu-Mei | 3 |
#4 | Tai Joseph Y | 3 |
#5 | Heron Iver | 2 |
#6 | Fusco Peter C | 2 |
#7 | Donets Mikhail | 2 |
#8 | Minetti Conceicao | 2 |
#9 | Wang Ming-Der | 2 |
#10 | Huang Chun-Hsien | 2 |
Publication | Filing date | Title |
---|---|---|
PL347058A1 | Streptococcal c beta protein compositions | |
PL346645A1 | IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE | |
CZ2000106A3 | Modified pneumolysin polypeptide having reduced hemolytic activity and process for preparing thereof | |
CZ200087A3 | Immunogenic conjugates containing peptine of meningococci of the group B and polysaccharide H. influenzae |